XENOGENIX GHK-CU Nasal Spray 50mg / 10ml

Skin quality support

GHK-CU has been studied for its potential role in improving the appearance and condition of ageing skin, including firmness, texture and overall skin renewal.

Collagen production support

Research has shown interest in GHK-CU because it may stimulate collagen synthesis, which is linked to skin structure, elasticity and tissue support.

Elastin and skin elasticity support

GHK-CU has been associated with increased elastin and glycosaminoglycan synthesis in research, both of which are important for skin flexibility and hydration-related structure.

Wound-healing and tissue-repair pathways

One of the strongest research areas around GHK-CU is wound healing, tissue repair and skin regeneration, especially in dermal repair models.

Anti-inflammatory activity

Studies and reviews describe GHK-CU as having anti-inflammatory properties, which may help explain its interest in recovery and tissue-regeneration research.

Antioxidant defence support

GHK-CU has been studied for its potential role in antioxidant defence and protection against oxidative stress, particularly in skin-related research.

Hair and follicle research interest

GHK-CU has appeared in research discussions around hair condition and follicle-related pathways, although this area should be worded carefully because evidence is less direct than the skin-repair research.

Blood vessel formation / angiogenesis support

Research reviews describe GHK-CU as supporting angiogenesis, which is the formation of new blood vessels, an important part of tissue repair and regeneration research.

Nerve-repair and neurotrophic research interest

GHK-CU has been studied for effects linked to nerve outgrowth and neurotrophic factors, making it interesting in broader regenerative research.

Healthy ageing and cellular-repair research

GHK-CU has been discussed as a natural peptide involved in multiple cellular repair and regeneration pathways, with interest in age-related decline and longevity-style research.

Suggested reference use: This product is supplied as a 50mg / 10ml nasal spray. As a general research reference, many users discuss using 1 spray per nostril once daily, with timing kept consistent. Individual use should be guided by a qualified healthcare professional.

1. What is GHK-CU?

GHK-CU is a copper-binding peptide made from the amino-acid sequence glycine-histidine-lysine combined with copper. It has been studied for its role in skin quality, collagen support, wound-healing pathways, tissue repair, antioxidant activity and inflammation-modulation research.

2. What is GHK-CU being researched for?

GHK-CU has been researched in areas such as skin ageing, collagen and elastin production, wound repair, tissue regeneration, oxidative stress, inflammation, hair-follicle activity and broader cellular-repair pathways.

3. What sort of ailments or conditions does it show promise for?

Research interest includes skin ageing, poor skin texture, wrinkles, slow wound-healing models, diabetic wound research, tissue-repair models, inflammation-related tissue stress, oxidative-stress pathways, hair and follicle support, and some experimental nerve and lung-repair models.

4. Is GHK-CU mainly a skin peptide?

Skin and wound-repair research are the strongest and most established areas for GHK-CU. Studies and reviews have linked it to collagen, elastin, glycosaminoglycan synthesis, dermal fibroblast support and improved skin-quality markers.

5. Can GHK-CU help with wrinkles or ageing skin?

GHK-CU has been studied in cosmetic and skin-ageing research, where it has been associated with improved skin appearance, firmness, elasticity and wrinkle-related parameters.

6. Can GHK-CU support collagen?

Yes, collagen support is one of the major research areas. GHK-CU has been reported to stimulate collagen production in fibroblast research and is frequently discussed for its role in extracellular matrix and skin-structure support.

7. Is GHK-CU being researched for wound healing?

Yes. GHK-CU has been studied in wound-healing and tissue-repair models, including human diabetic ulcer research and other wound-healing studies. This does not mean it should be used as a wound treatment without medical supervision.

8. Can GHK-CU help with inflammation?

GHK-CU has been described in research as having anti-inflammatory and antioxidant activity. This makes it interesting for recovery, tissue-stress and regenerative research.

9. Can GHK-CU help with hair growth?

There is research interest around GHK-CU and hair-follicle pathways, including studies looking at topical delivery and follicle activity.

10. Why is this product supplied as a nasal spray?

A nasal spray format is designed as a convenient non-injectable research format. Intranasal peptide research is an area of scientific interest, including studies looking at GHK-related compounds in ageing and neurological models.

11. When can people take it?

Many peptide users prefer consistent daily timing, often either morning or evening. Customers using medication, managing a medical condition, or combining compounds should get professional guidance first.

12. Can GHK-CU be used with other peptides?

GHK-CU is often discussed alongside other research peptides in the wellness and recovery space, but combining peptides should be approached carefully. Different compounds may overlap in effects, side effects, or mechanisms. Anyone considering peptide combinations should consult a qualified professional before mixing products, especially if using BPC-157, TB-500, GLP-1 products, hormone-related compounds, or prescription medication.

13. Can it be mixed with BPC-157 or TB-500?

GHK-CU, BPC-157 and TB-500 are all commonly discussed in tissue-repair and recovery research, but they are different compounds with different research profiles. “Some researchers study these compounds in related recovery pathways, but combinations should only be considered with professional guidance.”

1. Human diabetic-ulcer study — improved wound closure and fewer infections

A multicentre clinical study looked at topical glycyl-L-histidyl-L-lysine copper, also known as GHK-CU / prezatide copper, in patients with diabetic ulcers. The study reported that treatment with the copper peptide significantly improved wound closure compared with the control treatment. In plantar ulcers, median area closure was reported as 98.5% with the active treatment compared with 60.8% in the control group. This is one of the more important human studies behind GHK-CU’s reputation in wound-repair research.

Original article URL:

https://pubmed.ncbi.nlm.nih.gov/17147644/

2. Human facial-skin study — reduced wrinkle volume and wrinkle depth

A facial-skin study tested GHK-CU in nano-carriers on volunteers and reported strong cosmetic improvements. The study found that GHK-CU reduced wrinkle volume by 31.6% compared with Matrixyl 3000, and reduced wrinkle volume by 55.8% and wrinkle depth by 32.8% compared with control serum. This is useful for cosmetic and skin-quality research wording, but should still be presented as topical research rather than a guaranteed result.

Original article URL:

https://www.walshmedicalmedia.com/open-access/effects-of-ghkcu-on-mmp-and-timp-expression-collagen-and-elastin-production-and-facial-wrinkle-parameters-2329-8847-1000166.pdf

3. Fibroblast collagen study — stimulated collagen synthesis

A classic 1988 study tested GHK-CU on fibroblast cultures and reported that the tripeptide-copper complex stimulated collagen synthesis. Fibroblasts are important because they are the skin cells involved in producing collagen and extracellular matrix. This is one of the foundational studies behind GHK-CU’s collagen-support reputation.

Original article URL:

https://pubmed.ncbi.nlm.nih.gov/3169264/

Publisher page URL:

https://febs.onlinelibrary.wiley.com/doi/abs/10.1016/0014-5793%2888%2980509-X

4. Ischemic wound model — accelerated healing in difficult wounds

A 2003 study tested topical tripeptide-copper complex on ischemic open wounds, which are harder to heal because of reduced blood supply. The researchers concluded that topical TCC accelerated wound healing in ischemic open wounds, making this a strong tissue-repair research reference.

Original article URL:

https://pubmed.ncbi.nlm.nih.gov/14648529/

Publisher page URL:

https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1532-950X.2003.00515.x

5. Diabetic wound-healing matrix study — improved contraction, collagen and repair markers

A 2007 Life Sciences study incorporated biotinylated GHK into collagen matrices and tested it in diabetic wound healing. The study reported improved wound contraction, epithelialisation, collagen synthesis, antioxidant markers and repair-cell activity. This is useful because diabetic wound models are normally more difficult to repair than simple wound models.

Original article URL:

https://www.sciencedirect.com/science/article/abs/pii/S0024320506007211

6. Hair-growth delivery study — improved topical delivery and hair-growth cycle activity

A Bioactive Materials study explored GHK-CU in a special ionic-liquid microemulsion system for topical delivery. The paper describes GHK-CU as a strong hair-growth research compound and reported that the delivery system enhanced local delivery by around 3-fold, helping support interest in follicle and hair-growth research.

Original article URL:

https://pubmed.ncbi.nlm.nih.gov/38026438/

Full article URL:

https://www.sciencedirect.com/science/article/pii/S2452199X23003079

7. Lung inflammation and fibrosis model — reduced inflammation and fibrosis in silicosis research

A 2024 Redox Biology study tested GHK-CU in an experimental silicosis mouse model. The researchers identified peroxiredoxin 6 / PRDX6 as a molecular target and reported that GHK-CU could bind to PRDX6 and attenuate lung inflammation and fibrosis in the model, without significant systemic toxicity in that study. This is not a consumer claim, but it shows why researchers are interested in GHK-CU beyond skin research.

Original article URL:

https://pubmed.ncbi.nlm.nih.gov/38879894/

Full article URL:

https://www.sciencedirect.com/science/article/pii/S2213231724002155